相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing
Maria Elisa Mancuso et al.
LANCET (2021)
Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases
Francesca Tucci et al.
MOLECULAR THERAPY (2021)
Retrieval of vector integration sites from cell-free DNA
Daniela Cesana et al.
NATURE MEDICINE (2021)
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Christian Leborgne et al.
NATURE MEDICINE (2020)
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study
Beth Boulden Warren et al.
BLOOD ADVANCES (2020)
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A
Barbara A. Konkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
Monica Soldi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates
Michela Milani et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Gene Therapy
Katherine A. High et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice
Simone Merlin et al.
BLOOD ADVANCES (2019)
Advances and innovations in haemophilia treatment
Rob Peters et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Orthotopic liver transplantation for haemophilia A may not always lead to a phenotypic cure of haemophilia A: A case report
Yuji Suzuki et al.
HAEMOPHILIA (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice
Simone Merlin et al.
MOLECULAR THERAPY (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy
Michela Milani et al.
EMBO MOLECULAR MEDICINE (2017)
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
Vladimir N. Podust et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Liver-directed lentiviral gene therapy in a dog model of hemophilia B
Alessio Cantore et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animals
Jennifer A. Dumont et al.
THROMBOSIS RESEARCH (2015)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Jenny McIntosh et al.
BLOOD (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi et al.
SCIENCE (2013)
Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice
Alessio Cantore et al.
BLOOD (2012)
Codon optimization of human factor VIII cDNAs leads to high-level expression
Natalie J. Ward et al.
BLOOD (2011)
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
I. E. M. Den Uijl et al.
HAEMOPHILIA (2011)
A MicroRNA-regulated and GP64-pseudotyped Lentiviral Vector Mediates Stable Expression of FVIII in a Murine Model of Hemophilia A
Hideto Matsui et al.
MOLECULAR THERAPY (2011)
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Volker Schellenberger et al.
NATURE BIOTECHNOLOGY (2009)
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
Brian D. Brown et al.
BLOOD (2007)
Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg593 to Cys substitution
WS Bril et al.
THROMBOSIS AND HAEMOSTASIS (2006)
分享论文
